Nov 10, 2021 / 09:30PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Third Quarter 2021 Xenon Pharmaceuticals Incorporated Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your first speaker for today, Ms. Sherry Aulin, the Chief Financial Officer of Xenon Pharmaceuticals. Please go ahead.
Sherry Aulin - Xenon Pharmaceuticals Inc. - CFO
Thank you. Good afternoon, everyone. Thank you for joining us on our call and webcast to discuss our third quarter 2021 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer. Today, Ian will provide a corporate update on our proprietary programs and then turn the call over to Chris Kenney, who will provide a summary of the X-TOLE data and our XEN1101 plans moving forward. Chris Von Seggern will then provide context regarding the adult focal epilepsy market based on market research with leading KOLs and treating physicians. Lastly, I
Q3 2021 Xenon Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot